Curaleaf Holdings has started its 2026 Breast Cancer Action Month campaign, running from October 1 to 31 in stores nationwide (except Ohio). Customers can round up their purchase or donate $1 or $5 at checkout, with proceeds benefiting the Impact One Breast Cancer Foundation. Since 2020, Curaleaf and its customers have raised over $600,000 for breast cancer causes. This initiative highlights Curaleaf's commitment to social responsibility and supporting those affected by breast cancer.
Curaleaf's ongoing Breast Cancer Action Month campaign is noted alongside Pluang's health sector market data as of Oct 01, 2026 22:02 WIB. Among 100 priced health-sector US stocks tradable on Pluang, 25 rose and 74 fell today. Notable movers include CLPT (ClearPoint Neuro Inc) with a price of USD 11.50 and a 1-day change of -5.81%, NUWE (Nuwellis Inc) up 5.57% at USD 0.76, and HRTX (Heron Therapeutics Inc) up 5.26% at USD 0.33, with respective Pluang order activities and typical hold times.
Piper Sandler has set a $16 price target for V.F. Corp., suggesting a 12.2% upside from its current price of around $14.27. Analysts expect a slight decline in earnings per share to $0.51 and revenue to $2.70 billion, down 1.92% and 3.81% respectivel...
Raymond James increased its price target for e.l.f. Beauty from $100 to $117, reflecting the brand's significant retail expansion. e.l.f. Beauty's rhode brand is launching in over 500 Sephora stores across 19 new European markets, marking its first r...
Beneficient is set to report its Q3 2026 earnings on October 5, with analysts expecting $0.97 EPS and $13.1 million in revenue. The company is involved in disputes over allegedly fraudulent debt and equity claims linked to HCLP Nominees and former CE...
Robinhood Markets is broadening its platform with new features like AI-powered Robinhood Agents, crypto perpetual futures, earnings contracts, and social investing tools. The company plans to offer 24/7 trading for select U.S. stocks and ETFs, plus e...
Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Celsius Holdings securities between February 2025 and June 2026. The lawsuit alleges Celsius failed to disclose cardiac risks associated with its Alani Nu products, ...
